Phathom Pharmaceuticals Balance Sheet (2022-2025) | PHAT

Balance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 138.59M207.90M197.34M155.89M130.08M249.38M216.53M384.26M325.10M279.10M337.54M300.12M215.18M152.43M138.02M
Cash & Current Investments 138.59M207.90M197.34M155.89M130.08M249.38M216.53M384.26M325.10M279.10M337.54M300.12M215.18M152.43M138.02M
Receivables - Net 1.64M3.88M10.88M21.05M38.80M36.36M51.26M55.79M
Receivables 1.64M3.88M10.88M21.05M38.80M36.36M51.26M55.79M
Raw Materials 0.11M0.11M0.56M0.64M1.30M2.02M1.73M1.44M0.99M1.01M
Finished Goods 0.65M0.82M0.88M1.09M1.48M1.73M2.44M2.60M
Inventory 0.11M0.11M1.21M1.46M2.18M3.11M3.21M3.17M3.43M3.61M
Prepaid Assets 7.65M1.86M0.97M5.13M10.27M8.76M12.94M13.19M12.75M15.50M14.98M20.87M13.05M14.62M13.23M
Current Assets 145.74M209.26M197.81M160.51M139.84M257.72M226.73M397.43M340.31M304.79M373.82M360.13M264.90M218.88M207.78M
Non-Current Assets
Property, Plant & Equipment (Net) 0.71M0.88M0.83M1.21M1.27M1.16M1.98M2.15M1.96M1.81M1.66M1.48M1.35M1.24M1.16M
Other Non-Current Assets 0.81M0.81M0.81M0.51M0.51M3.75M3.75M2.86M2.87M2.86M2.86M2.86M2.86M2.86M2.86M
Non-Current Assets 3.31M4.25M4.12M4.30M4.17M7.32M10.27M16.41M16.18M14.59M13.22M18.18M29.31M31.34M32.51M
Assets 149.05M213.50M201.93M164.81M144.01M265.04M236.99M413.84M356.50M319.38M387.04M378.32M294.21M250.22M240.29M
Liabilities
Current Liabilities
Accounts Payables 2.86M5.76M7.13M10.00M4.80M4.17M5.79M12.60M8.40M7.66M7.13M10.51M11.62M4.01M1.07M
Payables 2.86M5.76M7.13M10.00M4.80M4.17M5.79M12.60M8.40M7.66M7.13M10.51M11.62M4.01M1.07M
Accumulated Expenses 7.57M13.78M13.29M14.68M8.02M15.45M13.46M17.20M16.54M27.30M35.76M53.23M43.03M64.30M65.35M
Other Accumulated Expenses 0.06M0.04M0.03M0.15M0.06M0.02M0.02M0.12M0.90M0.73M1.79M3.04M2.81M4.87M4.79M
Current Leases 0.49M0.63M0.69M0.71M0.71M0.72M0.72M0.73M0.73M0.72M0.68M0.50M0.32M0.24M0.59M
Current Deferred Revenue 0.28M2.39M7.11M16.48M9.91M20.19M19.78M17.27M21.53M24.34M
Total Current Liabilities 11.39M21.07M22.88M26.24M14.44M21.55M23.98M38.78M43.46M47.01M65.29M85.73M74.03M91.82M93.12M
Non-Current Liabilities
Non-Current Debt 91.04M92.43M93.88M95.26M96.64M97.81M99.26M137.84M149.02M174.42M175.73M201.41M203.25M205.14M207.09M
Non-Current Deffered Revenue 109.53M119.80M123.40M299.82M302.53M321.19M322.39M333.26M343.81M347.00M348.98M
Operating Leases 1.08M1.39M1.25M1.10M0.94M0.79M0.63M0.46M0.29M0.13M0.59M2.12M
Other Non-Current Liabilities 7.50M7.50M7.50M7.50M7.50M7.50M7.50M9.70M9.70M10.45M10.75M11.50M11.50M11.50M11.50M
Total Non-Current Liabilities 103.51M213.00M220.85M232.12M226.71M239.94M247.26M476.90M495.30M542.75M563.41M620.40M621.08M644.55M651.32M
Total Liabilities 111.01M220.50M228.35M239.62M234.21M247.44M254.76M486.60M505.00M553.21M574.16M631.90M632.58M656.05M662.82M
Shareholder's Equity
Total Debt 91.04M92.43M93.88M95.26M96.64M97.81M99.26M137.84M149.02M174.42M175.73M201.41M203.25M205.14M207.09M
Common Equity 38.03M-7.00M-26.42M-74.81M-90.19M17.60M-17.77M-72.76M-148.50M-233.83M-187.11M-253.58M-338.38M-405.83M-422.53M
Shareholder's Equity 38.03M-7.00M-26.42M-74.81M-90.19M17.60M-17.77M-72.76M-148.50M-233.83M-187.11M-253.58M-338.38M-405.83M-422.53M
Liabilities and Shareholders Equity 149.05M213.50M201.93M164.81M144.01M265.04M236.99M413.84M356.50M319.38M387.04M378.32M294.21M250.22M240.29M
Retained Earnings -570.03M-620.96M-672.05M-727.09M-764.91M-805.87M-849.12M-928.68M-1011.54M-1102.98M-1188.56M-1263.01M-1357.33M-1433.14M-1463.11M
Treasury Shares 0.92M0.70M0.48M0.25M0.03M19.0019.0019.0019.0019.0019.0019.0019.0019.0019.00